> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Notice Correction on ANDA Approval Withdrawal
- URL: https://www.fdaweb.com/notice-correction-on-anda-approval-withdrawal/
- Published: 2021-06-15T12:00:00.000Z
- Updated: 2026-09-14T17:03:26.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5149540

*Federal Register* notice: FDA is correcting a 5/12 notice about the withdrawal of approval of 12 ANDAs from multiple applicants. That notice indicated that FDA was withdrawing the approval of ANDA 060164, Nystatin Ointment, held by Lederle Laboratories. However, the notice was published with an incorrect application number for the product. This notice corrects that error. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2021-06-15/pdf/2021-12557.pdf?ref=fdaweb.com).